Background Aggressive T-cell lymphomas represent 10 ％to 15 ％of non-Hodgkins lymphomas in adults.Patients withrelapsed or refractory disease are generally considered incurable with conventional therapies.ATG had been used in theconditioning regimen to reduce the incidence of GvHD for a long time especially in the matched unrelated donor HSCT.